TLDR
- Energy sector shares declined following Trump’s prediction of an imminent end to Iran tensions
- Brent crude plummeted more than 9% to $89.94; WTI decreased 8.5% to $86.72 per barrel
- Occidental Petroleum led premarket S&P 500 declines, sliding 3.2%
- G-7 nations indicated readiness to deploy strategic oil reserves, potentially pressuring prices further
- CrowdStrike gained ground following a Morgan Stanley analyst upgrade highlighting AI capabilities
Oil stocks experienced significant declines Tuesday morning following President Donald Trump’s statement that the Iran conflict would conclude “very soon,” sparking a substantial retreat in crude oil valuations and energy sector equities.
Brent crude futures plunged over 9% to reach $89.94 per barrel. West Texas Intermediate declined 8.5% to settle at $86.72. Both benchmarks had previously reached their highest trading levels since 2022 prior to the president’s remarks.
Occidental Petroleum experienced the steepest decline among S&P 500 energy constituents during premarket hours, dropping 3.2%. ConocoPhillips decreased 1.7%.
Chevron and ExxonMobil each retreated more than 1%. These major oil companies had already been facing headwinds as the Middle East tensions directly impacted their operational capabilities.
Chevron had implemented a temporary suspension of activities at a natural gas facility located off the Israeli coastline. ExxonMobil’s liquefied natural gas collaborator, QatarEnergy, encountered difficulties reaching its customer base as maritime vessels were unable to navigate through the Persian Gulf.
G-7 Nations Weigh Strategic Petroleum Reserve Deployment
Compounding the bearish pressure, the Group of Seven countries announced Monday their preparedness to tap into emergency petroleum stockpiles if circumstances warrant. The G-7 collectively maintains approximately 1.2 billion barrels in strategic reserves.
Treasury officials refrained from authorizing an immediate release during their Monday gathering, though they released a joint statement declaring they “stand ready to take necessary measures.” Should such a release materialize, crude valuations would likely face additional downward pressure, negatively impacting energy sector profitability.
U.S. equity index futures also registered losses by Tuesday morning. Dow futures retreated 71 points, S&P 500 futures declined 12 points, and Nasdaq 100 futures slipped 24 points.
CrowdStrike Advances Following Morgan Stanley Analyst Boost
The market showed divergent movements across sectors. CrowdStrike shares advanced after Morgan Stanley analysts elevated their rating on the cybersecurity specialist. Analysts emphasized the company’s robust artificial intelligence positioning and favorable expansion prospects.
Hewlett Packard Enterprise posted gains despite reporting quarterly revenues below analyst projections. Market observers highlighted robust appetite for its artificial intelligence infrastructure products.
Oracle shares demonstrated modest movement ahead of earnings results scheduled for release following market close. Market participants monitored developments attentively.
BioNTech American Depositary Receipts retreated after the pharmaceutical manufacturer projected disappointing revenue expectations for fiscal year 2026.
Vail Resorts reduced its annual outlook following an exceptionally poor snowfall season across western U.S. regions during recent decades, which significantly diminished accessible skiing areas through February.
Bunge Global ticked upward after the agricultural commodities firm unveiled a $3 billion share repurchase initiative.
Carnival Corporation edged downward after Bernstein analysts cautioned that its strategy of avoiding fuel hedging could create vulnerability to energy cost increases linked to Middle East tensions.
Kohl’s declined following disappointing quarterly sales figures, extending a pattern of underperformance for the department store chain.
Casey’s General Stores slipped after third-quarter revenues fell short of analyst forecasts.
Vertex Pharmaceuticals advanced after preliminary results from a late-stage clinical trial of its investigational treatment for a rare autoimmune kidney condition demonstrated encouraging outcomes.
As of Tuesday morning, petroleum prices continued experiencing heightened volatility, with market participants monitoring potential additional announcements from the White House or G-7 regarding subsequent actions.





